Matches in SemOpenAlex for { <https://semopenalex.org/work/W69591616> ?p ?o ?g. }
- W69591616 endingPage "946" @default.
- W69591616 startingPage "935" @default.
- W69591616 abstract "A working group supported by the Office of Rare Diseases of the National Institutes of Health formulated neuropathologic criteria for corticobasal degeneration (CBD) that were subsequently validated by an independent group of neuropathologists. The criteria do not require a specific clinical phenotype, since CBD can have diverse clinical presentations, such as progressive asymmetrical rigidity and apraxia, progressive aphasia, or frontal lobe dementia. Cortical atrophy, ballooned neurons, and degeneration of the substantia nigra have been emphasized in previous descriptions and are present in CBD, but the present criteria emphasize tau-immunoreactive lesions in neurons, glia, and cell processes in the neuropathologic diagnosis of CBD. The minimal pathologic features for CBD are cortical and striatal tau-positive neuronal and glial lesions, especially astrocytic plaques and thread-like lesions in both white matter and gray matter, along with neuronal loss in focal cortical regions and in the substantia nigra. The methods required to make this diagnosis include histologic stains to assess neuronal loss, spongiosis and ballooned neurons, and a method to detect tau-positive neuronal and glial lesions. Use of either the Gallyas silver staining method or immunostains with sensitive tau antibodies is acceptable. In cases where ballooned neurons are sparse or difficult to detect, immunostaining for phospho-neurofilament or alpha-B-crystallin may prove helpful. Methods to assess Alzheimer-type pathology and Lewy body pathology are necessary to rule out other causes of dementia and Parkinsonism. Using these criteria provides good differentiation of CBD from other tauopathies, except frontotemporal dementia and Parkinsonism linked to chromosome 17, where additional clinical or molecular genetic information is required to make an accurate diagnosis." @default.
- W69591616 created "2016-06-24" @default.
- W69591616 creator A5000409879 @default.
- W69591616 creator A5006709022 @default.
- W69591616 creator A5009533777 @default.
- W69591616 creator A5011835428 @default.
- W69591616 creator A5012877366 @default.
- W69591616 creator A5026333864 @default.
- W69591616 creator A5039383646 @default.
- W69591616 creator A5042083351 @default.
- W69591616 creator A5047838139 @default.
- W69591616 creator A5060420616 @default.
- W69591616 creator A5061360555 @default.
- W69591616 creator A5062983762 @default.
- W69591616 creator A5066429603 @default.
- W69591616 creator A5089576120 @default.
- W69591616 date "2002-11-01" @default.
- W69591616 modified "2023-10-14" @default.
- W69591616 title "Office of Rare Diseases Neuropathologic Criteria for Corticobasal Degeneration" @default.
- W69591616 cites W1556490889 @default.
- W69591616 cites W1957167348 @default.
- W69591616 cites W1963912731 @default.
- W69591616 cites W1966001133 @default.
- W69591616 cites W1966280878 @default.
- W69591616 cites W1966307326 @default.
- W69591616 cites W1968989400 @default.
- W69591616 cites W1975043679 @default.
- W69591616 cites W1975111736 @default.
- W69591616 cites W1979000028 @default.
- W69591616 cites W1979834756 @default.
- W69591616 cites W1980524252 @default.
- W69591616 cites W1984420254 @default.
- W69591616 cites W1984513074 @default.
- W69591616 cites W1984827962 @default.
- W69591616 cites W1986748953 @default.
- W69591616 cites W1994926763 @default.
- W69591616 cites W1998319561 @default.
- W69591616 cites W2000277357 @default.
- W69591616 cites W2001454001 @default.
- W69591616 cites W2004877989 @default.
- W69591616 cites W2006345162 @default.
- W69591616 cites W2011448175 @default.
- W69591616 cites W2015020748 @default.
- W69591616 cites W2018505720 @default.
- W69591616 cites W2020057468 @default.
- W69591616 cites W2020697171 @default.
- W69591616 cites W2023039543 @default.
- W69591616 cites W2023660164 @default.
- W69591616 cites W2031026212 @default.
- W69591616 cites W2033900520 @default.
- W69591616 cites W2034284124 @default.
- W69591616 cites W2037467359 @default.
- W69591616 cites W2039415480 @default.
- W69591616 cites W2045671840 @default.
- W69591616 cites W2049032266 @default.
- W69591616 cites W2051003532 @default.
- W69591616 cites W2052742260 @default.
- W69591616 cites W2053172888 @default.
- W69591616 cites W2055013864 @default.
- W69591616 cites W2055391668 @default.
- W69591616 cites W2059559114 @default.
- W69591616 cites W2059848978 @default.
- W69591616 cites W2060365226 @default.
- W69591616 cites W2061153776 @default.
- W69591616 cites W2061363233 @default.
- W69591616 cites W2066640986 @default.
- W69591616 cites W2067310881 @default.
- W69591616 cites W2076788135 @default.
- W69591616 cites W2077422298 @default.
- W69591616 cites W2077907915 @default.
- W69591616 cites W2082515665 @default.
- W69591616 cites W2090060333 @default.
- W69591616 cites W2090115258 @default.
- W69591616 cites W2094826609 @default.
- W69591616 cites W2095268950 @default.
- W69591616 cites W2103829129 @default.
- W69591616 cites W2122118003 @default.
- W69591616 cites W2126264983 @default.
- W69591616 cites W2126497695 @default.
- W69591616 cites W2143604549 @default.
- W69591616 cites W2152506041 @default.
- W69591616 cites W2156182885 @default.
- W69591616 cites W2164319722 @default.
- W69591616 cites W2164925809 @default.
- W69591616 cites W2166617413 @default.
- W69591616 cites W2170906442 @default.
- W69591616 cites W2413259662 @default.
- W69591616 cites W2725718031 @default.
- W69591616 cites W35263452 @default.
- W69591616 cites W4240218176 @default.
- W69591616 cites W4243799182 @default.
- W69591616 cites W63470078 @default.
- W69591616 doi "https://doi.org/10.1093/jnen/61.11.935" @default.
- W69591616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12430710" @default.
- W69591616 hasPublicationYear "2002" @default.
- W69591616 type Work @default.
- W69591616 sameAs 69591616 @default.
- W69591616 citedByCount "569" @default.